- Home
- SGRY
as 04-17-2025 4:00pm EST
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 2.7B | IPO Year: | 2015 |
| Target Price: | $37.57 | AVG Volume (30 days): | 988.5K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.50 - $33.97 | Next Earning Date: | 05-06-2025 |
| Revenue: | $3,114,300,000 | Revenue Growth: | 13.52% |
| Revenue Growth (this year): | 10.91% | Revenue Growth (next year): | 9.15% |
Stock Insider Trading Activity of Surgery Partners Inc. (SGRY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | SGRY | Chief Human Resources Officer | Mar 14 '25 | Sell | $23.78 | 74 | $1,759.72 | 44,839 | |
| Baldock Jennifer | SGRY | Chief Admin & Dev Officer | Mar 14 '25 | Sell | $23.94 | 612 | $14,651.28 | 236,047 | |
| Webb William Trenton | SGRY | American Group President | Mar 14 '25 | Sell | $23.70 | 138 | $3,270.60 | 74,521 | |
| Doherty David T | SGRY | Chief Financial Officer | Mar 10 '25 | Sell | $24.02 | 6,733 | $161,726.66 | 150,868 | |
| Burkhalter Danielle | SGRY | Chief Human Resources Officer | Mar 10 '25 | Sell | $24.14 | 1,240 | $29,933.60 | 44,839 | |
| Baldock Jennifer | SGRY | Chief Admin & Dev Officer | Mar 10 '25 | Sell | $23.97 | 3,008 | $72,101.76 | 236,047 | |
| Brittenham Marissa | SGRY | Chief Strategy Officer | Mar 10 '25 | Sell | $24.09 | 3,156 | $76,028.04 | 63,408 | |
| Bane Harrison R. | SGRY | National Group President | Mar 10 '25 | Sell | $24.16 | 4,045 | $97,727.20 | 126,520 | |
| Webb William Trenton | SGRY | American Group President | Mar 10 '25 | Sell | $24.06 | 2,057 | $49,491.42 | 74,521 | |
| Doherty David T | SGRY | Chief Financial Officer | Feb 7 '25 | Sell | $25.61 | 13,641 | $349,346.01 | 150,868 |
Latest Surgery Partners Inc. News
SGRY Breaking Stock News: Dive into SGRY Ticker-Specific Updates for Smart Investing
StockStory
a day ago
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest
StockStory
8 days ago
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks
StockStory
11 days ago
3 Reasons SGRY is Risky and 1 Stock to Buy Instead
StockStory
16 days ago
Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
MT Newswires
a month ago
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating
MT Newswires
a month ago
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating
GuruFocus.com
a month ago
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion
Thomson Reuters StreetEvents
a month ago
Q4 2024 Surgery Partners Inc Earnings Call
Compare SGRY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SGRY Surgery Partners Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.